For instance, predicting the onset of secondary-progressive multiple sclerosis is accomplished using genetic and nongenetic factors, with the HLA-A*02:01 allele conferring a decreased risk for MS and also contributing to decreased hazards for SPMS [38]. This evidence concerns the gene HLA-A and myeloid sarcoma.